Examining the Impact of Different IV Fluids during Cancer Surgery: A Comparison of Ringer Lactate and Plasmalyte intravenous fluids in major tumour removal with heated chemotherapy during surgery.
Phase 4
- Conditions
- Health Condition 1: C00-D49- Neoplasms
- Registration Number
- CTRI/2024/02/062356
- Lead Sponsor
- Deep Vinod
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All patients who are treated with CRS + HIPEC at our institute.
Exclusion Criteria
Patient not willing to participate in the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary objective is to compare lactate levels with intravenous infusion of Ringer’s lactate versus Plasmalyte in patients undergoing CRS HIPEC surgery. <br/ ><br>Timepoint: At Baseline, before HIPEC, after HIPEC and post operative day 1 <br/ ><br>
- Secondary Outcome Measures
Name Time Method To compare changes in pH & electrolyte equilibrium (sodium, potassium, calcium & chloride) in the two groups. <br/ ><br>Timepoint: At Baseline, before HIPEC, after HIPEC & post operative day 1